谷歌浏览器插件
订阅小程序
在清言上使用

Nivolumab (NIVO) + Chemotherapy (chemo) Vs Chemo As First-Line (1L) Treatment for Advanced Gastric Cancer/gastroesophageal Junction Cancer/esophageal Adenocarcinoma (GC/GEJC/EAC): 5-Year (y) Follow-Up Results from CheckMate 649.

Journal of Clinical Oncology(2025)

引用 0|浏览0
AI 理解论文
溯源树
样例
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要